Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2003
06/12/2003CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003CA2468971A1 Method of activating protein
06/12/2003CA2468905A1 Cheese flavour ingredient and method of its production
06/12/2003CA2468744A1 Hybrid antibodies
06/12/2003CA2468565A1 Transgenic animals bearing human iglambda light chain genes
06/12/2003CA2467738A1 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003CA2467597A1 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
06/12/2003CA2467363A1 Polycistronic expression of antibodies
06/12/2003CA2464897A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/11/2003EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody
06/11/2003EP1318198A1 Process for producing a recombinant polypeptide involving the addition of an inhibitor of chymotrypsins to the cell culture medium
06/11/2003EP1318195A1 A structure for presenting desired peptide sequences
06/11/2003EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
06/11/2003EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
06/11/2003EP1317541A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/11/2003EP1317540A2 Imidazoline receptor homologs
06/11/2003EP1317538A1 Novel compounds
06/11/2003EP1317537A2 G-csf analog compositions and methods
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
06/11/2003EP1317528A2 Lipoxygenase
06/11/2003EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
06/11/2003EP1317486A1 Interferon-alpha induced gene
06/11/2003EP1317475A2 Peptides for use in culture media
06/11/2003EP1317474A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/11/2003EP1317186A1 Improved bioactive whey protein hydrolysate
06/11/2003EP0848755B1 Vegf-related protein
06/11/2003EP0707641B1 An enzyme with protease activity
06/11/2003EP0694075B1 Thermostable dna topoisomerase v
06/11/2003EP0690873B1 Growth differentiation factor-8
06/11/2003EP0662086B1 Protein l and hybrid proteins thereof
06/11/2003EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use
06/11/2003EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
06/11/2003CN1423704A Process for producing tripeptides
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423660A Antibodies
06/11/2003CN1423659A Recombinant gelatins
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/11/2003CN1423565A 精子因子oscillogenin Sperm factor oscillogenin
06/11/2003CN1423523A Human ex vivo immune system
06/11/2003CN1422959A Secondary lymphoid chemotactic factor SLC preparation method
06/11/2003CN1422958A Human vascular endothelial growth factor and its polyclonal antibody preparation and method for constructing eukaryotic expression vector
06/11/2003CN1422957A Method for preparing bioactive micro peptide of plant protein
06/11/2003CN1422954A Human interferon alpha 2a gene cDNA code modification recombination sequence
06/11/2003CN1422952A Human interferon alpha 2b gene cDNA code modification recombination sequence
06/11/2003CN1422870A Fusional protein with intensified activity of internal red-blood-cell formation element
06/11/2003CN1422868A Receptor targeting chimeric toxin with junctional sequence
06/11/2003CN1422863A Recombinant chimeric peptide antigen detecting HCMV antibody and production method thereof
06/10/2003US6576820 Rice cell transformed with a gene encoding the protein; useful as an ingredient in food and for preventing and treating arteriosclerosis and coronary heart diseases; lowers serum cholesterol
06/10/2003US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell
06/10/2003US6576467 Methods for producing recombined antibodies
06/10/2003US6576455 Structure-based designed herbicide resistant products
06/10/2003US6576454 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme
06/10/2003US6576437 Stimulus-inducible protein kinase complex and methods of use therefor
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576431 Treatment for myocardial infarction; enhancing clot lysis
06/10/2003CA2234208C Influenza vaccine
06/10/2003CA2166367C Live recombinant avian vaccine using an avian herpesvirus as vector
06/10/2003CA2121121C Preparation of recombinant borrelia proteins
06/10/2003CA2107340C Monoclonal antibodies against human tnf-binding protein i (tnf-bp i)
06/10/2003CA2081879C Monoclonal antibodies to polyacrylate polymers
06/10/2003CA2065323C Isolation and purification of lung surfactant protein
06/05/2003WO2003046576A1 Fibrinogen biopolymer marker and its use for the screening of type ii diabetes
06/05/2003WO2003046575A1 Biopolymer marker indicative of normal human
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046573A2 Protein biopolymer markers predictive of insulin resistance
06/05/2003WO2003046572A2 Biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046571A2 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046570A2 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046569A1 Fibronectin precursor biopolymer marker predictive of alzheimers disease
06/05/2003WO2003046568A2 Protein biopolymer markers indicative of a disease state
06/05/2003WO2003046567A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046566A2 Pedf biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046565A2 Ig lambda biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046564A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046558A2 Complement c3 precursor biopolymer markers predictive of type ii diabetes
06/05/2003WO2003046557A2 Hp biopolymer markers predictive of insulin resistance
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046226A1 Methylotrophic bacterium for the production of recombinant proteins and other products
06/05/2003WO2003046204A2 Humanized collagen antibodies and related methods
06/05/2003WO2003046195A1 Method for generating a site-specific library of variants
06/05/2003WO2003046188A1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans
06/05/2003WO2003046187A1 Method for producing a recombinant polypeptide
06/05/2003WO2003046180A2 Human cdnas and proteins and uses thereof
06/05/2003WO2003046162A2 Process for the production of polypeptides in mammalian cell cultures
06/05/2003WO2003046160A2 Methods of increasing protein expression levels
06/05/2003WO2003046158A1 A method for preparing the recombinant human glucagon like peptide-1 (7-37)
06/05/2003WO2003046155A1 Ϝ-glutamylcysteine-producing yeast
06/05/2003WO2003046150A2 Glycoprotein remodeling using endoglycanases
06/05/2003WO2003046138A2 Genetically stable expression vector
06/05/2003WO2003046133A2 Regulatory nucleic acid assay for diagnostic and library screens
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2003046013A1 Fusion protein having enhanced in vivo activity of erythropoietin
06/05/2003WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046009A1 ANTI-IL13 RECEPTOR α1 NEUTRALIZING ANTIBODY
06/05/2003WO2003046004A2 Macroglobulin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046003A2 Plasma protease c1 biopolymer markers predictive of alzheimers disease
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045996A1 Chromatographic purification of recombinant human erythropoietin
1 ... 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 ... 1125